EUCTR2018-001221-98-AT进行中(未招募)1 期
DEXAMETHASONE AS ADJUVANT FOR PERIPHERAL NERVE BLOCKADE: A RANDOMIZED, TRIPLE-BLINDED AND CROSSOVER STUDY IN VOLUNTEERS - Dexamethason adjuvant study
Medical University of Vienna, Department of Clinical Pharmacology0 个研究点目标入组 24 人开始时间: 2018年5月14日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中(未招募)
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
入选标准
- •Healthy males
- •Healthy, according to the medical history, ECG, vital signs, laboratory results and physical examination as determined by the Investigator/Sub-Investigator
- •Signed written informed consent prior to inclusion in the study
- •18-55 years old inclusive
- •Clearly detectable ulnar nerve at the non-dominant arm in ultrasound evaluation, according to the main investigators opinion (P.M.)
- •BMI: 18 to 35 kg/m2
- •Ability to understand the full nature and purpose of the study, including possible risks and side effects
- •Ability to co-operate with the investigator and to comply with the requirements of the entire study
- •Availability to volunteer for the entire study duration and willing to adhere to all protocol requirements
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 24
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Any clinically relevant abnormalities at ECG (12 leads)
- •Any clinically relevant abnormal physical findings
- •Any clinically relevant abnormal laboratory values indicative of physical illness
- •Ascertained or presumptive hypersensitivity to the active principle and/or formulations ingredients of the study drug
- •History of anaphylaxis to drugs or allergic reactions in general, which the investigator considers may affect the outcome of the study
- •If one of the investigated nerves are not clearly visible in ultrasound
- •Relevant history of malignancy, of renal, hepatic, cardiovascular, respiratory, gastrointestinal, musculoskeletal, skin (particularly at the site of drug application), haematological, endocrine or neurological diseases that may interfere with the aim of the study
- •Any psychiatric illnesses
- •Using other medications during 1 week before the start of IMP application including OTC
- •Participation in another clinical study investigating another IMP within 1 month prior to screening
- •Blood donations during 4 weeks prior to this study History of drug or alcohol abuse (>2 drinks/day, defined according to USDA Dietary Guidelines 2015)
- •Other objections to study participation in the opinion of the investigator
研究者
相似试验
尚未招募
2 期
DEXAMETHASONE AS ADJUVANT FOR PERIPHERAL NERVE BLOCKADE: A RANDOMIZED, TRIPLE-BLINDED AND CROSSOVER STUDY IN VOLUNTEERS- dexamethasone for peripheral nerve blocksHealthy volunteersDRKS00014604Medizinische Universität Wien24
进行中(未招募)
不适用
Dexmedetomidine (=Drug for Block Prolongation) used for Regionla Anaesthetic Blockade: A Dosefinding Study in Volunteers24 Volunteers recieve an ultrasound guided ulnar nerve block, and apparted into 4 groups. Group 1 receives 3ml Ropivacaine 0.75% without adjuvants. Group 2-4 receives 3ml Ropivacain 0.75% with three different doses of dexmedetomidine (50, 100,150 mcg). The aim of the study is to eveluate the optimal dose regarding sensory duration of nerve block without side effects of dexmedetomidine.EUCTR2013-003790-10-ATMedizinische Universität Wien, Universitätsklinik für Klinische Pharmakologie
已完成
不适用
HEADING TOWARDS BETTERMENT OF PAINLESS DELIVERY OF PREGNANT WOMEN.CTRI/2018/09/015751A80
尚未招募
Unknown
The effects of perineural dexamethasone as a adjunct to ropivacaine fascia iliaca block for hip fracture surgery; A Randomized Controlled TrialKCT0008845Konyang University Hospital62
进行中(未招募)
1 期
Oral dexamethasone as an adjunct to a peripheral nerve block in patients undergoing surgery of the forearm and hand.EUCTR2021-000428-36-DKZealand University Hospital, Department of Anaesthesiology180
